Mike Tyson, former heavyweight champion of the world, has joined forces with Wesana Health to open the public conversation about psychedelics as a treatment for traumatic brain injury and associated depression.
Since his retirement, Tyson has suffered from depression, violent rage, and suicidal ideation as a result of the physical trauma endured throughout the course of his career. Despite his erratic actions in the past and the severity of his depression, Mike Tyson told Reuters, “I AM CURED,” in an interview this year.
This miracle claim comes after Tyson’s experience with psilocybin mushrooms, or magic mushrooms, as a medical treatment for his TBI.
Traumatic Brain Injury is a brain dysfunction caused by an outside force to the head. Commonly occurring as the result of one or more sports injuries or motor vehicle accidents, symptoms may be immediate or delayed. Confusion, blurry vision, and difficulty with focus or concentration are common symptoms in adults suffering from TBI. As we have learned from athletes like Tyson and Daniel Carcillo, former NHL athlete and founder and CEO of Wesana Health, depression and suicidal thoughts are also possible symptoms of the condition.
“Wesana Health is an emerging life sciences company championing the development and delivery of therapies, including psychedelics, to treat traumatic brain injury (TBI) and related conditions. Through extensive clinical research and academic partnerships, we’re developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.”
Wesana Health is currently focusing on treatments for TBI, PTSD, anxiety and depression.
According to Drs. Alan K. Davis, PhD and Roland R. Griffiths, PhD of Johns Hopkins School of Medicine, major depressive disorder, seen in these patients with TBI or other past trauma, is seriously under treated.
Their study conducted with the Center for Psychedelic and Consciousness Research and Department of Psychiatry and Behavioral Sciences of Johns Hopkins found that a “randomized clinical trial found that psilocybin-assisted therapy was efficacious in producing large, rapid, and sustained antidepressant effects in patients with major depressive disorder.”1
On May 13, 2021, Wesana Health announced in conjunction with the World Boxing Council a multi-year joint research effort into the treatment of TBI with Psychedelics. This makes the WBC the first governing body in sports to study the benefits of Psilocybin and how it can offer long-term health protection to athletes.
1Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(5):481–489. doi:10.1001/jamapsychiatry.2020.3285